Markets
Anavex Life Sciences Corp. (AVXL)
AVXLNASDAQ-GSBiotechnology: Biological Products (No Diagnostic Substances)
$1.13
-0.0950 (-7.79%) today
Regular session, Nov 10, 3:33 PM ET
-7.79% 1D
- Market cap
- $104.28m
- P/E
- –
- EPS, last 4 quarters
- $-0.1500
- Dividend yield
- –
- Day range
- $1.12 to $1.23
- 52-week range
- $1.07 to $7.60
- Average volume
- 1.09m
- Previous close
- $1.22
Earnings
next estimate $-0.1100Next report Nov 24, 2026
Sep 2025
+15.4%
Dec 2025
+40.0%
Mar 2026
–
Jun 2026
+200.0%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$10.84m | -$6.78m | -$6.48m | $6.74m |
| Net income | -$9.83m | -$5.68m | -$5.34m | $7.82m |
News
8 latest- Anavex Life Sciences Corp. Appoints Terrie Kellmeyer, Ph.D. as Chief Executive Officer and PresidentFintel · Nov 3, 2026
- FDA Clears Anavex's IND For Blarcamesine In Fragile X Syndrome RTTNews · Oct 16, 2026
- Anavex Life Sciences Reports Q3 2026 Results, Returns To Profit On Expense Recovery; Stock Up RTTNews · Aug 25, 2026
- Notable Monday Option Activity: AVXL, OUT, ASIXBNK Invest · May 11, 2026
- Anavex Life Sciences Names Terrie Kellmeyer As Interim CEO RTTNews · May 6, 2026
- Weekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses RTTNews · Mar 27, 2026
- Anavex Withdraws EU Application For Blarcamesine In Early Alzheimer's, Stock Down RTTNews · Mar 25, 2026
- Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year?Zacks · Mar 18, 2026
The company
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded clinical-stage biopharmaceutical company developing innovative therapeutics for the treatment of central nervous system diseases with high unmet medical need.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- anavex.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.